Skip to content
Posted on March 25, 2023 by: tove

Tianyun International Announced 2022 Annual Results

Southeast Asia Chronicle
Posted on March 25, 2023 by: tove

Tianyun International Announced 2022 Annual Results

  • Home
  • SEAPRWire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact

Tag: clinical

  • Home
  • clinical
Posted on February 15, 2023 by: tove

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, …

Continue Reading
Posted on January 12, 2023 by: tove

Novotech Acquires European CRO, Strengthens Global Operations

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory …

Continue Reading
Posted on January 12, 2023 by: tove

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a …

Continue Reading
Posted on January 12, 2023 by: tove

Avance Clinical 庆祝GlobalReady成功 超过40家生物技术客户进入计划

San Francisco, Jan 12, 2023 – (亚太商讯 via SEAPRWire.com) – 超过 40 家生物技术客户现在正在利用 Avance Clinical 的 GlobalReady 计…

Continue Reading
Posted on January 11, 2023 by: tove

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

SAN FRANCISCO, CA, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady …

Continue Reading
Posted on January 10, 2023 by: tove

China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate

HONG KONG, Jan 10, 2023 – (ACN Newswire via SEAPRWire.com) – China Biotech Services Holdings Limited (the “Group”; stock code: 8037. HK) has announced that …

Continue Reading
Posted on January 5, 2023 by: tove

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing …

Continue Reading
Posted on December 20, 2022 by: tove

Novotech is Gold Sponsor at Biotech Showcase 2023

SYDNEY, AU, Dec 20, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor …

Continue Reading
Posted on December 15, 2022 by: tove

Data Shows 50% of New Trials Have Sites in Asia Pacific

SYDNEY, AU, Dec 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication …

Continue Reading
Posted on November 11, 2022 by: tove

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

SYDNEY, AU, Nov 11, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, …

Continue Reading
Posted on November 10, 2022 by: tove

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

HONG KONG, Nov 10, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as “PureFDA”) announced the …

Continue Reading
Posted on October 25, 2022 by: tove

Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

SYDNEY, AU, Oct 25, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest …

Continue Reading
Posted on October 17, 2022 by: tove

The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval

SYDNEY, AU, Oct 17, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar …

Continue Reading
Posted on October 7, 2022 by: tove

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

SYDNEY, AU, Oct 7, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global …

Continue Reading
Posted on September 28, 2022 by: tove

Avance Clinical Wins International Health Award for Biotech CRO Services

SYDNEY, AU, Sep 28, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South …

Continue Reading
Posted on September 6, 2022 by: tove

Avance Clinical 宣布收购北美 CRO扩大生物技术的后期服务

SYDNEY, AU, Sep 6, 2022 – (亚太商讯 via SEAPRWire.com) – 澳大利亚生物技术 CRO 公司 Avance Clinical 已通过收购 CRO 合作伙伴公司 C3 Res…

Continue Reading
Posted on September 6, 2022 by: tove

Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

SYDNEY, AU, Sep 6, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the …

Continue Reading
Posted on September 5, 2022 by: tove

Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC

SYDNEY, Sep 5, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new …

Continue Reading
Posted on September 2, 2022 by: tove

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a …

Continue Reading
Posted on August 30, 2022 by: tove

Avance 临床赞助商在 2022 年 Informa Pharma Intelligence Awards 中获得年度生物技术公司奖

ADELAIDE, AUS, Aug 30, 2022 – (亚太商讯 via SEAPRWire.com) – Avance Clinical 是澳大利亚领先的国际生物技术 CRO,在 2022 年 Informa…

Continue Reading

Posts navigation

1 2 3 4 5 6

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • SEAPRWire

Latest News

  • Tianyun International Announced 2022 Annual Results March 25, 2023
  • Analogue Grows FY2022 Revenue and Contracts Awarded by 21.0% and 41.8% Respectively Defying Challenging Market Conditions March 25, 2023
  • 天韵国际公布2022年全年业绩 March 25, 2023
  • 安乐工程2022全年收益及获授合约逆市增加21.0%及41.8% March 24, 2023
  • EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong March 24, 2023
  • 祖龙娱乐发布2022年度业绩 March 24, 2023
  • 赤子城科技有限公司 (9911.HK) 公佈2022全年業績 March 24, 2023
  • 医思健康与诺辉健康达成战略合作 共同推动「宫证清」在港上市 March 24, 2023
  • GigaCloud Technology Inc Ushering In A Bright Future As China Reopening in 2023 March 24, 2023
  • VCREDIT Delivered Rapid Growth in Loan Volume, Registered Users Hit 126.8 million in FY2022 March 24, 2023
  • 解封元年,大健云仓大有可为! March 24, 2023
  • Eisai to Present Research from Oncology Portfolio at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer March 24, 2023
  • Mitsubishi Corporation: PoC Launched in Portland, Oregon to Develop Smart Multifamily Apartment March 24, 2023
  • 盛业2022年业绩稳健增长 科技收入大幅提升 March 24, 2023
  • 东曜药业战略转型成果显著 2022年营收大增479% “一地化·端到端”的ADC产业化平台竞争优势凸显 March 24, 2023

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2023 Southeast Asia Chronicle All Rights Reserved By Seachronicle.Com